VXRT
Vaxart, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.40
−5.79%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-18.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 20, 2026 | Bono Raquel C. · director | A-Award | 78,800 | $0.00 |
| Oct 20, 2026 | Bono Raquel C. · director | A-Award | 157,400 | $0.45 |
| Jul 20, 2026 | Finney Kevin · director | A-Award | 39,400 | $0.00 |
| Jul 20, 2026 | Finney Kevin · director | A-Award | 78,700 | $0.51 |
| Jul 17, 2026 | BREITMEYER JAMES B · director | A-Award | 16,610 | $0.51 |
| Jul 17, 2026 | Wheadon David E. · director | A-Award | 39,400 | $0.00 |
| Jul 17, 2026 | HERON ELAINE J · director | A-Award | 39,400 | $0.00 |
| Jul 17, 2026 | BREITMEYER JAMES B · director | A-Award | 8,315 | $0.00 |
| Jul 17, 2026 | Watson W. Mark · director | A-Award | 78,700 | $0.51 |
| Jul 17, 2026 | Watson W. Mark · director | A-Award | 39,400 | $0.00 |
| Jul 17, 2026 | Wheadon David E. · director | A-Award | 78,700 | $0.51 |
| Jul 17, 2026 | HERON ELAINE J · director | A-Award | 78,700 | $0.51 |
| May 26, 2026 | Watson W. Mark · director | Purchase | 10,000 | $0.65 |
| May 21, 2026 | Grasman Jeroen Nicolaas · officer: Chief Financial Officer | F-InKind | 31,395 | $0.61 |
| May 1, 2026 | BREITMEYER JAMES B · director | A-Award | 78,800 | $0.00 |
| May 1, 2026 | BREITMEYER JAMES B · director | A-Award | 157,400 | $0.74 |
| Mar 31, 2026 | Tucker Sean · officer: SVP, Chief Scientific Officer | F-InKind | 3,924 | $0.65 |
| Mar 31, 2026 | Cummings James F. · officer: Chief Medical Officer | F-InKind | 3,292 | $0.65 |
| Mar 26, 2026 | Lo Steven · director, officer: President, Chief Exec Officer | F-InKind | 126,028 | $0.69 |
| Mar 26, 2026 | Cummings James F. · officer: Chief Medical Officer | F-InKind | 30,551 | $0.69 |
| Mar 26, 2026 | Tucker Sean · officer: SVP, Chief Scientific Officer | F-InKind | 36,418 | $0.69 |
| Mar 26, 2026 | Berg Edward B · officer: SVP, General Counsel | F-InKind | 36,418 | $0.69 |
| Mar 20, 2026 | Berg Edward B · officer: SVP, General Counsel | F-InKind | 8,072 | $0.63 |
| Mar 20, 2026 | Tucker Sean · officer: SVP, Chief Scientific Officer | F-InKind | 8,072 | $0.63 |
| Mar 20, 2026 | Lo Steven · director, officer: President, Chief Exec Officer | F-InKind | 22,425 | $0.63 |
| Mar 20, 2026 | Cummings James F. · officer: Chief Medical Officer | F-InKind | 6,772 | $0.63 |
| Mar 18, 2026 | Tucker Sean · officer: SVP, Chief Scientific Officer | A-Award | 200,000 | $0.00 |
| Mar 18, 2026 | Tucker Sean · officer: SVP, Chief Scientific Officer | A-Award | 410,000 | $0.68 |
| Mar 18, 2026 | Berg Edward B · officer: SVP, General Counsel | A-Award | 115,000 | $0.00 |
| Mar 18, 2026 | Cummings James F. · officer: Chief Medical Officer | A-Award | 227,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 3Increased 0Reduced 0Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Heritage Wealth Advisors | New Position | 29,655 | Aug 14, 2026 |
| LVM CAPITAL MANAGEMENT LTD/MI | Unchanged | 25,000 | Jul 9, 2026 |
| KINGSWOOD WEALTH ADVISORS, LLC | Unchanged | 10,005 | Oct 23, 2026 |
| KINGSWOOD WEALTH ADVISORS, LLC | New Position | 10,005 | Jul 27, 2026 |
| FIRST COMMAND ADVISORY SERVICES, INC. | New Position | 40 | May 7, 2026 |
| ARCHER INVESTMENT CORP | Unchanged | 15 | May 4, 2026 |
| Archer Investment Corp | Unchanged | 15 | Aug 19, 2026 |
| First Command Advisory Services, Inc. | Sold Out | 0 | May 7, 2026 |
| LVM CAPITAL MANAGEMENT LTD/MI | Sold Out | 0 | Jul 9, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 20, 2026